Xeljanz and Xeljanz XR are prescription drugs used to treat certain autoimmune disorders, such as ulcerative colitis. They are part of a group of drugs called Janus kinase (JAK) inhibitors and are ...

Pfizer’s Xeljanz pill has been approved in the US in psoriatic arthritis, for people who have not responded to, or cannot take, other disease-modifying drugs. Xeljanz has been FDA-approved since ...

Xeljanz, also known as tofacitinib, is a Janus kinase (JAK) inhibitor used for moderate-to-severe ulcerative colitis. JAK ...

Xeljanz (tofacitinib) is approved at the higher dose of 10 mg twice daily in patients with ulcerative colitis, although this can be reduced to 5 mg twice daily in patients who respond well.

ICER's 2023 report highlights five drugs with unsupported price increases, leading to $815 million in excess costs for U.S.

Tofacitinib 11mg, 22mg; ext-rel tabs. Swallow whole. 11mg once daily. Switching from immediate-rel to XR tabs: start XR tab the day following the last immediate-rel 5mg dose. Moderate to severe ...

Xeljanz, an anti-inflammatory therapy, generated $321M in sales with a ~36% YoY drop globally, and sales from cancer therapy ...